New York Life Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$35K Sell
281
-3,454
-92% -$413K 1.7% 5
2016
Q4
$430K Buy
3,735
+40
+1% +$4.62K 2.04% 4
2016
Q3
$436K Buy
3,695
+1,412
+62% +$171K 2.15% 4
2016
Q2
$277K Sell
2,283
-1,002
-31% -$114K 1.34% 15
2016
Q1
$355K Sell
3,285
-957
-23% -$99.1K 1.53% 10
2015
Q4
$436K Sell
4,242
-117
-3% -$11.8K 1.87% 4
2015
Q3
$407K Sell
4,359
-331
-7% -$32K 1.81% 4
2015
Q2
$457K Sell
4,690
-213
-4% -$21.3K 1.9% 4
2015
Q1
$493K Buy
4,903
+4
+0.1% +$407 1.96% 4
2014
Q4
$512K Buy
4,899
+497
+11% +$52.4K 2.02% 4
2014
Q3
$469K Buy
4,402
+88
+2% +$9.13K 1.94% 3
2014
Q2
$451K Sell
4,314
-458
-10% -$46.3K 1.9% 3
2014
Q1
$469K Buy
4,772
+66
+1% +$6.12K 2.07% 3
2013
Q4
$431K Buy
4,706
+482
+11% +$44.4K 1.96% 4
2013
Q3
$366K Sell
4,224
-1,033
-20% -$92.7K 1.84% 5
2013
Q2
$451K Buy
+5,257
New +$446K 2.08% 5

Other funds holding JNJ

New York Life Trust's JNJ Position: Q1 2017 in Review

New York Life Trust reduced its Johnson & Johnson (JNJ) stake by 92% in Q1 2017, selling an estimated $413K and leaving 281 shares worth $35K. The position accounts for 1.7% of the portfolio, ranked #5.

New York Life Trust first reported a position in JNJ in Q2 2013 and has held it in 16 quarters since. The position peaked at $512K in Q4 2014. 2,350 funds tracked by Wall St. Rank hold JNJ as of Q1 2017.

  • New York Life Trust held 281 shares of Johnson & Johnson worth $35K as of Q1 2017.
  • New York Life Trust sold 3,454 Johnson & Johnson shares in Q1 2017, an estimated $413K.
  • Johnson & Johnson made up 1.7% of New York Life Trust's portfolio in Q1 2017, its #5 holding.
  • New York Life Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's Johnson & Johnson position peaked at $512K in Q4 2014.
  • 2,350 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.